Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02983006
Title Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors New York University School of Medicine
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Laura and Isaac Perlmutter Cancer Center New York New York 10016 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field